ArticleBMC gastroenterology2026
A linear clinical prediction model and nomogram evaluating risk of portal vein thrombosis in liver cirrhosis.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAs one of the complications of liver cirrhosis, portal vein thrombosis (PVT) brings a significant clinical challenge. To find the predictive clinical variables evaluating the probability of PVT, a prediction model was established and a nomogram was built for visualization. MATERIALS AND
methodsOur study selected 245 cirrhosis patients admitted in First Hospital of Jilin University during August 2020 to June 2024, the majority of whom were admitted during July 2022 to June 2023. All patients were randomly separated into a training set and a validation set. Binary logistic and Lasso regression were used to establish predictive models with the occurrence of PVT events within 24 months after discharge as the clinical outcome.
resultsIn discovery set, 64 (26.1%) of them had events of PVT within 24 months after their discharge. A linear model "ASP" was constructed with logarithm of alkaline phosphatase (Log
conclusionWe finally screened out three clinical variables identifying high-risk PVT patients in liver cirrhosis beforehand. ALP level might be a potential clinical parameter connected to PVT, but need to be further verified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.